Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 7:08 PM View:  | Tarsus Pharmaceuticals, Inc. (TARS) | 18-Mar-24 | Option Sale | 4,766 | $30.60 | $145,840.00 | (8%) 58.84K to 54.08K | |
| 19-Mar-24 7:08 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-24 | Option Exercise | 12,938 | -- | -- | 28% 45.9K to 58.84K | |
| 21-Jul-23 5:46 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 19-Jul-23 | Market Sale (Planned) | 2,400 | $20.05 | $48,120.00 | (5%) 48.21K to 45.81K | (11%) |
| 12-Jun-23 5:25 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 08-Jun-23 | Market Sale (Planned) | 100 | $20.00 | $2,000.00 | (< 1%) 48.19K to 48.09K | (11%) |
| 08-Jun-23 7:16 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 07-Jun-23 | Sale (Planned) | 2,500 | $19.34 | $48,350.00 | (5%) 50.69K to 48.19K | |
| 08-Jun-23 7:16 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 06-Jun-23 | Sale (Planned) | 2,143 | $18.61 | $39,881.20 | (4%) 52.83K to 50.69K | |
| 23-Mar-23 7:46 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 23-Mar-23 | Sale | 372 | $12.15 | $4,519.80 | (< 1%) 53.2K to 52.83K | |
| 23-Mar-23 7:46 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 22-Mar-23 | Sale | 357 | $12.64 | $4,512.48 | (< 1%) 53.56K to 53.2K | |
| 23-Mar-23 7:46 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 21-Mar-23 | Sale | 349 | $12.89 | $4,498.61 | (< 1%) 53.91K to 53.56K | |
| 21-Mar-23 7:08 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 20-Mar-23 | Sale | 358 | $12.61 | $4,514.38 | (< 1%) 54.27K to 53.91K | |
| 21-Mar-23 7:08 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 17-Mar-23 | Sale | 339 | $13.28 | $4,501.92 | (< 1%) 54.6K to 54.27K | |
| 17-Mar-23 6:17 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Mar-23 | Option Sale | 336 | $13.43 | $4,512.48 | (< 1%) 54.94K to 54.6K | |
| 17-Mar-23 6:17 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-23 | Option Exercise | 4,790 | -- | -- | 10% 50.15K to 54.94K | |
| 17-Nov-22 5:30 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Nov-22 | Sale (Planned) | 6,857 | $17.72 | $121,506.00 | (12%) 56.59K to 49.73K | |
| 26-Aug-22 4:25 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Aug-22 | Option Exercise | 5,188 | $9.42 | $48,879.20 | 10% 51.4K to 56.59K | |
| 10-Nov-21 6:29 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 08-Nov-21 | Market Sale (Planned) | 1,889 | $28.11 | $53,099.80 | (4%) 52.09K to 50.2K | 2% |
| 08-Nov-21 5:49 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 05-Nov-21 | Market Sale (Planned) | 11 | $28.11 | $309.21 | (< 1%) 52.1K to 52.09K | < 1% |
| 08-Nov-21 5:49 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 04-Nov-21 | Market Sale (Planned) | 100 | $28.03 | $2,803.00 | (< 1%) 52.2K to 52.1K | < 1% |
| 04-Nov-21 7:03 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 02-Nov-21 | Market Sale (Planned) | 6,000 | $26.78 | $160,690.00 | (10%) 58.2K to 52.2K | (4%) |
| 14-Sep-21 4:51 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 10-Sep-21 | Option Exercise | 6,943 | $7.05 | $48,973.30 | 13% 53.85K to 60.8K | |
| 14-Sep-21 4:51 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 10-Sep-21 | Market Option Sale | 2,593 | $22.15 | $57,434.90 | (4%) 60.8K to 58.2K |